Squadron Capital Management LLC → C4 Therapeutics, Inc. CCCC

Stake: — Shares: — Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-31

DTC 11.12

30,427,514 shares short · +27.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $18.03M

Point72 Asset Mgmt

Other 13D/G Filings on C4 Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-27	SCHEDULE 13G	BlackRock, Inc.	—	—	view →
2021-06-15	SC	COBRO VENTURES OPPORTUNITY FUND, L.P.	—	—	view →

Other Filings by Squadron Capital Management LLC

Filed	Form	Issuer	Stake	Shares
2026-05-27	SCHEDULE 13G	InMed Pharmaceuticals Inc. INM	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →